scholarly journals Austerity Redux: The Post‐pandemic Wave of Budget Cuts and the Future of Global Public Health

Global Policy ◽  
2021 ◽  
Author(s):  
Alexander Kentikelenis ◽  
Thomas Stubbs
2011 ◽  
Vol 33 (2) ◽  
pp. 310-316 ◽  
Author(s):  
A. C. K. Lee ◽  
J. A. Hall ◽  
K. L. Mandeville

2020 ◽  
Vol 19 (2) ◽  
pp. 237-252
Author(s):  
Sienho Yee

Abstract There has never been any State practice in pursuing State responsibility for alleged malfeasances in pandemics. What effect does this absence of practice have on the framework of applicable law regarding this pursuit of State responsibility? How can we make sense of this absence in the context of global public health? One way would be to see the absence as reflecting a lex specialis providing for no State responsibility for any alleged malfeasances; another as reflecting States’ assessment that there is no or slight chance of success even under a lex generalis not excluding potential responsibility. The former appears more consonant with the uniform lack of practice in pursuing State responsibility over the long course of history of dealing with pandemics. If there can be a better state of affairs, it will be up to States to search for it and to bring it to fruition in the future.


Author(s):  
Ronghua Ding ◽  
Jinzhao Long ◽  
Mingzhu Yuan ◽  
Yuefei Jin ◽  
Haiyan Yang ◽  
...  

The continued global pandemic of coronavirus disease 2019 (COVID-19) poses a serious threat to global public health and social stability and it has become a serious global public health problem. Unfortunately, existing diagnostic and therapeutic approaches for the prevention and control of COVID-19 have many shortcomings. In recent years, the emerging CRISPR/Cas technology can complement the problems of traditional methods. Biological tools based on CRISPR/Cas systems have been widely used in biomedicine. In particular, they are advantageous in pathogen detection, clinical antiviral therapy, drug, and vaccine development. Therefore, CRISPR/Cas technology may have great potential for application in the prevention and control of COVID-19 and emerging infectious diseases in the future. This article summarizes the existing applications of CRISPR/Cas technology in infectious diseases with the aim of providing effective strategies for the prevention and control of COVID-19 and other emerging infectious diseases in the future.


PsycCRITIQUES ◽  
2013 ◽  
Vol 58 (11) ◽  
Author(s):  
Patrick H. DeLeon ◽  
Michaela Shafer

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 469-471 ◽  
Author(s):  
Bhagyashri Vijay Chaudhari ◽  
Priya P. Chawle

“A lesson learned the hard way is a lesson learned for a lifetime.” Every bad situation hurts; however, it sure does teach us something a lesson. In the same manner of a new lesson for Human lifetime, history is observing 'The Novel COVID-19 ’, a very horrible and strange situation created due to fighting with a microscopic enemy. WHO on 11 February 2020 has announced a name for new disease as - 19 and has declared as a global public health emergency and subsequently as pandemic because of its widespread. This began as an outbreak in December 2019, with its in Wuhan, the People Republic of China has emerged as a public health emergency of international concern. is the group of a virus with non-segmented, single-stranded and positive RNA genome. This bad situation of pandemic creates new scenes in the life of people in a different manner, which will be going to be life lessons for them. Such lessons should be kept in mind for the safety of living beings and many more things. In this narrative review article, reference was taken from a different article published in various databases which include the view of different authors and writers on the "Lessons to be from Corona".


Sign in / Sign up

Export Citation Format

Share Document